Dianthus Therapeutics, Inc.

DNTH ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
4	May 28, 2024	4
4	May 28, 2024	4
4	May 28, 2024	4
424B3	May 28, 2024	424B3
8-K	May 28, 2024	8-K
424B3	May 9, 2024	424B3
10-Q	May 9, 2024	10-Q
8-K	May 9, 2024	8-K
ARS	Apr 11, 2024	ARS
DEFA14A	Apr 11, 2024	DEFA14A
DEF 14A	Apr 11, 2024	DEF 14A
SC 13D/A	Apr 1, 2024	SC 13D/A
4	Apr 1, 2024	4
EFFECT	Mar 27, 2024
CORRESP	Mar 25, 2024
S-8	Mar 21, 2024	S-8
S-1/A	Mar 21, 2024	S-1/A
10-K	Mar 21, 2024	10-K
8-K	Mar 21, 2024	8-K
SC 13G/A	Feb 14, 2024	SC 13G/A
SC 13G/A	Feb 14, 2024	SC 13G/A
SC 13G/A	Feb 14, 2024	SC 13G/A
SC 13G/A	Feb 9, 2024	SC 13G/A
CORRESP	Feb 7, 2024
S-1/A	Feb 7, 2024	S-1/A

← Newer Page 9 of 27 · 660 filings Older →